DUBLIN–(BUSINESS WIRE)–The “Bifurcation
Lesions Market Analysis by Application (Coronary Vascular and Peripheral
Vascular), by Region (North America, Europe, Asia Pacific, Latin
America, MEA) and Segment Forecasts, 2014 – 2025” report has
been added to Research and Markets’ offering.
The global bifurcation lesions market is expected to reach USD 2.8
billion by 2025, growing at a CAGR of 5.6%
Technological developments and supportive government initiatives for
reimbursement are likely to drive the market during the forecast period.
Increasing geriatric population and unhealthy lifestyle are responsible
for growth in incidence of cardiovascular disorders. Furthermore,
increase in approval & commercialization of innovative devices and
expected entry of new devices for treatment of bifurcation lesions in
the coming years are likely to drive the market.
In addition, rising affordability, increase in demand for minimally
invasive procedures, and growing medical tourism are also boosting
demand for bifurcation lesions procedures across the globe. According to
various studies, procedures for coronary bifurcation lesions comprise
approximately 20% of total percutaneous coronary interventions.
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Bifurcation Lesions Market Industry Outlook
Chapter 4. Bifurcation Lesions Market: Application Outlook
Chapter 5. Bifurcation Lesions Market: Regional Outlook
Chapter 6. Competitive Landscape
Chapter 7. Company Profiles
- Boston Scientific Corporation
- C. R. Bard, Inc.
- Cardinal Health